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Cytotoxic T-cell-derived granzyme B activates the apoptotic
protease ICE-LAP3
Arul M. Chinnaiyan*, William L. Hanna†, Kim Orth*, Hangjun Duan*, 
Guy G. Poirier‡, Christopher J. Froelich† and Vishva M. Dixit*
Cytotoxic T lymphocytes (CTLs) and natural killer (NK)
cells provide immune surveillance against viruses and
neoplasms, and play a central role in the pathogenesis
of autoimmune disease, AIDS and graft rejection [1,2].
Thus, it is important to understand the precise molecular
mechanism(s) whereby cytotoxic lymphocytes destroy
susceptible target cells. Granule-mediated cytotoxicity
requires a combination of both perforin and granzyme B
[3]. Perforin polymerizes to form transmembrane
channels and presumably allows granzyme B access to
target cell substrates, which until recently, were
unknown. One clue to the identity of the physiological
substrate(s) activated by granzyme B comes from its
unusual specificity for cleaving synthetic substrates
after aspartate residues [4]. Members of the ICE/CED-3
family of cysteine proteases are prime candidates as
they are important apoptotic effectors [5,6] and are
expressed as zymogens, which can be processed to
form active heterodimeric enzymes after cleavage at
specific aspartate residues. Previous studies have
shown that granzyme B proteolytically activates the cell
death effector Yama/CPP32/apopain [7,8] (referred to
here as Yama). Here we report that granzyme B also
activates ICE-LAP3/Mch3/CMH-1 (referred to here as
ICE-LAP3), which, along with Yama and Mch2, forms a
subset of the ICE/CED-3 family of cysteine proteases
most closely related to the Caenorhabditis elegans cell
death gene, CED-3 [6,9]. Importantly, Jurkat T cells
incubated with granzyme B and a sublytic concentration
of perforin undergo apoptosis, which is preceded by the
activation of endogenous ICE-LAP3. Thus, we propose
that granzyme B mediates apoptosis by directly
engaging the target cell’s death effector machinery,
which is probably composed of an arsenal of
intracellular, CED-3-like cysteine proteases.
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Results and discussion
To determine whether ICE-LAP3 and Yama were directly
activated by granzyme B, histidine-tagged proteins were
generated by in vitro transcription–translation and subse-
quently purified by nickel-affinity chromatography as pre-
viously described [8]. Purified, 35S-labeled pro-ICE-LAP3
(p35) or Yama (p32) proteins were incubated with purified
granzyme B [10] and processing was monitored over time
(Fig. 1a). Several ICE-LAP3 species were generated,
including 25, 20, 10 and 5 kDa forms (Fig. 1a). The p25
form, probably an intermediate, appeared within 5 minutes
of incubation, suggesting that the first cleavage of ICE-
LAP3 occurred between the p20 and p10 subunits (Fig.
1a,b). The next cleavage was complete within 30 minutes
and removed the 5 kDa pro-domain (Figs. 1a,b), forming a
putative active heterodimeric enzyme (p20–p10). When
incubated alone, ICE-LAP3 did not undergo autoactiva-
tion. As previously reported, Yama is also processed by
granzyme B [7,8], but less efficiently than ICE-LAP3 (Fig.
1a). Experimental evidence that granzyme B-processed
ICE-LAP3 is active was obtained by assaying for cleavage
of poly(ADP-ribose) polymerase (PARP) (Fig. 1c). Unlike
ICE, ICE-LAP3 and other members of the CED-3 sub-
family can cleave PARP into signature apoptotic fragments
[11]. To exclude the possibility of direct cleavage of PARP
by granzyme B, the processed ICE-LAP3 was incubated
with a selective inhibitor of granzyme B (anti-GraB) as pre-
viously described [8]. As predicted, granzyme B could
mediate the proteolytic activation of ICE-LAP3 (Fig. 1c).
In addition, granzyme B-processed ICE-LAP3 cleaved the
fluorescent substrate z-DEVD-AFC (Fig. 1d), which
mimics the PARP cleavage site P1–P4 tetrapeptide [11].
Previous studies have shown that purified granzyme B, in
combination with perforin, triggers apoptosis of suscepti-
ble target cells ([12]; C.J.F., unpublished observations)
Thus, we used this paradigm of granule-mediated apopto-
sis to study endogenous ICE-LAP3 activation. Consistent
with previous studies, treatment with granzyme B and
perforin induced apoptosis of Jurkat cells, as measured by
DNA strand breakage (Fig. 2a). ICE-LAP3 is expressed
as a 35 kDa pro-enzyme which is processed to active sub-
units (p20–p10) by engagement of Fas/APO-1 or the
receptor for tumor necrosis factor (TNF) (Fig. 2b; [9,13]).
Treatment of Jurkat cells with granzyme B and a sub-lytic
concentration of perforin resulted in rapid proteolytic acti-
vation of endogenous ICE-LAP3 (within 20 minutes; Fig.
2b). Granzyme B or perforin alone failed to cause similar
processing (Fig. 2b). ICE-LAP3 activation preceded the
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Figure 1
Proteolytic activation of ICE-LAP3 by granzyme B in vitro. (a) Time course of
granzyme B-mediated processing of ICE-LAP3 and Yama. Purified in vitro
translated His6-tagged ICE-LAP3 and Yama were incubated with purified
granzyme B [10] as described [8]. Briefly, 48 ml of 35S-labeled protein was
incubated with 20 pmole purified granzyme B in a total volume of 50 ml. At the
various time points, aliquots were taken for analysis by SDS–PAGE. ICE-LAP3 or
Yama alone did not undergo processing (data not shown). (b) Schematic
representation of the ICE-LAP3 and Yama proteins. Processing sites at specific
Asp residues are shown. Within 5 minutes, ICE-LAP3 is cleaved at site 1,
forming a p25 intermediate; cleavage at site 2 occurs by 30 min, resulting in the
removal of the pro-domain (p5) and generation of active subunits (p20–p10).
Yama is cleaved less efficiently than ICE-LAP3 as full conversion to active
subunits takes at least 2 h. Like ICE-LAP3, Yama is cleaved at site 1, forming a
p20 intermediate, and subsequently at site 2, resulting in the generation of active
subunits (p17–p12). (c) Granzyme B-processed ICE-LAP3 and Yama cleave
PARP into the signature 85 kDa apoptotic fragment. After 4 h of incubation,
520 pmole of anti-GraB was added to the reaction mix from (a), in order to
neutralize granzyme B activity [8]. After 15 min, 1 ml (150 ng) of purified PARP
[14] was added and the reaction was allowed to proceed for 2 h. The control
reaction containing PARP alone, or PARP plus granzyme B and anti-GraB, was
carried out under identical conditions, except that ICE-LAP3 or Yama were not
added. The reaction buffer contained 50 mM Hepes (pH 7.4), 0.1 M NaCl, 0.1 %
CHAPs and 10 % sucrose. All incubations were carried out at 37 °C in 10 mM
DTT. Samples were analyzed by immunoblotting with anti-PARP monoclonal
antibody C-2-10 as described [14]. (d) Granzyme B-processed ICE-LAP3
cleaves the fluorescent substrate z-DEVD-AFC. In vitro translated ICE-LAP3 was
incubated alone or with granzyme B for various times: squares, granzyme B;
diamonds, ICE-LAP3; circles, granzyme B plus ICE-LAP3. To measure ICE-LAP3
activity, a colormetric assay was performed as described [16]. Briefly, ICE-LAP3
activity was measured by incubation with 50 mM z-DEVD-AFC (Enzyme Systems
Products, Dublin, California) for 30 min at 30 °C and data expressed as relative
absorbance units. Similar results were obtained with granzyme-B activated Yama
(data not shown).
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Figure 2
Granzyme B, in combination with perforin, induces activation of endogenous
ICE-LAP3 in Jurkat cells. (a) Kinetics of apoptosis in Jurkat cells treated with
granzyme B (GraB) and perforin (PFP). Jurkat cells were pulsed with GraB
(60 nM) for 1 h, washed and resuspended in PFP (120 hemolytic U ml–1) or
treated with anti-Fas monoclonal antibody (100 ng ml–1, Kamiya Biomedical
Co.). Results are expressed as percent FITC–TUNEL-positive cells: Fas at
20 min, 2 % apoptotic; Fas at 70 min, 23 % apoptotic; Fas at 240 min, 69 %
apoptotic; GraB/PFP at 20 min, 0 % apoptotic; GraB/PFP at 70 min, 5 %
apoptotic; GraB/PFP at 240 min, 32 % apoptotic. Less than 10 % propidium
iodide staining was seen in control cells treated with GraB or PFP alone.
Human GraB was purified as described [10]. Human perforin was isolated
from 1 M NaCl extracts of YT NK cell granules using ion metal affinity
chromatography. Hemolytic activity was measured by sheep RBC assay. Active
fractions were pooled and concentrated by ultrafiltration and stored at –20 °C
in 2 mM EDTA and 0.1 % BSA. Target cells (106 per ml of RPMI containing
0.05 % BSA) were pulsed with isolated granzyme B in microfuge tubes. After
four washes, targets were resuspended in RPMI with 2 mM CaCl2 and PFP
was added dropwise to the cell suspension. After incubation for designated
times at 37 °C, samples were processed. Apoptosis was measured by terminal
deoxyribonucleotidyl transferase-catalyzed labeling of DNA strand breaks with
FITC–dUTP [15] and/or propidium iodide staining followed by flow cytometry.
Data acquisition consisted of 10 000 events per analysis on the Coulter Epic
V; histograms show cell count on y axis and log scale of fluorescence intensity
on x axis. Original histograms were scanned with the HP III scanner interfaced
with a Macintosh LC475 computer and converted to PICT files for display. 
(b) Granzyme B in combination with perforin, activates endogenous ICE-LAP3
in Jurkat cells. Samples from (a) were analyzed for processing of the precursor
form of ICE-LAP3 and Yama into active subunits. Immunoblotting was carried
out using an antibody directed against the p20 subunit of ICE-LAP3 [9,13] 
or antibodies against the p17 and p12 subunits of Yama [13]; 2 × 106 Jurkat
cells were used in each sample. Samples were analyzed at 240 min unless
otherwise stated.
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apoptotic phenotype, supporting a role for ICE-LAP3 as
an effector in granzyme B-mediated apoptosis (ICE-
LAP3 activation was detected within 20 minutes, where-
as apoptotic changes were detected in 240 minutes (Fig.
2). Interestingly, activation of Yama was only detected at
the late 240-minute time point (Fig. 2b), suggesting that
granzyme B may prefer ICE-LAP3 as its physiological
substrate. Future studies will address the kinetics of
granzyme B-mediated processing of ICE-LAP3, Yama
and presumably other ICE-like enzymes activated by
granzyme B.
In conclusion, it is becoming apparent that CTLs partici-
pate in the ‘assisted suicide’ of susceptible target cells by
inserting the cytotoxic protease granzyme B and by acti-
vating the death receptor Fas/APO-1. The apoptotic pro-
tease Yama has been shown to serve as a substrate for
granzyme B in vitro, and in this report we identify a second
viable, and more efficiently cleaved substrate, ICE-LAP3.
These results suggest a model in which granzyme B
engages a target cell’s suicide machinery by activating a
subset of proteases in the ICE/CED-3 family (Fig. 3).
Yama and ICE-LAP3 are both activated during Fas-medi-
ated [9,13] and granzyme B-mediated cell death, suggest-
ing a convergence of the two distinct apoptotic pathways
involved in cell-mediated immunity.
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Figure 3
Model of granzyme B-mediated activation of the ICE-like proteases
most related to C. elegans CED-3. Cytotoxic lymphocytes use
granzyme B to engage the apoptotic proteases of the target cells they
destroy. Yama/CPP32 [7,8] and ICE-LAP3 (this study) have both been
shown to be activated by granzyme B. We propose that other CED-3
subfamily members will also be activated by granzyme B.
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